Medicine
Potassium citrate 15 mEq tablet
Potassium citrate 15 mEq tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in a tight container at 20°–25°C (68°–77°F), Excursions permitted…
Key facts
- Active ingredient (INN)
- Potassium citrate
- Brand
- Sold under the generic name
- Strength
- 15 mEq
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets
- Manufacturers
- Strides PharmaIndiaBioComp PharmaBryant Ranch Prepack
- Origin register
- US FDA, United States
- Storage
- Store in a tight container at 20°–25°C (68°–77°F), Excursions permitted between 15° and 30°C (59° and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A12BA02 Potassium citrate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 December 2013
- Identifiers
- RxCUI 898490, 199376, 199381DailyMed set ID 8f5f7078-3c2d-406f-9222-b82a0f79d168, 5f38b02c-703c-4fc2-b833-654e41bd617f, b32fe71a-4a58-04a1-64d3-bc3cc4a895bfNDC 72162-2478, 42543-408, 44523-415Application ANDA206813, NDA019071
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 42543-408-01 | Strides PharmaIndia | 1 November 2017 |
| 100 tablet in 1 bottle | 44523-415-01 | Biocomp Pharma | 23 December 2013 |
| 100 tablet in 1 bottle | 72162-2478-1 | Bryant Ranch Prepack | 1 May 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 August 1985 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Potassium citrate
Clinical summary
Potassium citrate is an anti-coagulant indicated for the management of renal tubular acidosis, among other approved uses. It is available as extended-release tablets and tablets for oral use. MedsAcross supplies Potassium citrate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Potassium citrateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Potassium Citrate prescribing information (Biocomp Pharma) · U.S. National Library of Medicine, DailyMed
Need Potassium citrate 15 mEq tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.